1. Home
  2. ICUCW vs REGCO Comparison

ICUCW vs REGCO Comparison

Compare ICUCW & REGCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SeaStar Medical Holding Corporation Warrant

ICUCW

SeaStar Medical Holding Corporation Warrant

HOLD

Current Price

$0.03

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Logo Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

REGCO

Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

HOLD

Current Price

$22.46

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUCW
REGCO
Founded
N/A
N/A
Country
United States
United States
Employees
18
500
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ICUCW
REGCO
Price
$0.03
$22.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
ICUCW
REGCO
Relative Strength Index (RSI) 68.19 44.72
Support Level $0.01 $22.16
Resistance Level $0.02 $22.80
Average True Range (ATR) 0.01 0.22
MACD 0.00 -0.02
Stochastic Oscillator 48.57 32.97

Price Performance

Historical Comparison
ICUCW
REGCO

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

Share on Social Networks: